JP2021522240A5 - - Google Patents
Info
- Publication number
- JP2021522240A5 JP2021522240A5 JP2020559388A JP2020559388A JP2021522240A5 JP 2021522240 A5 JP2021522240 A5 JP 2021522240A5 JP 2020559388 A JP2020559388 A JP 2020559388A JP 2020559388 A JP2020559388 A JP 2020559388A JP 2021522240 A5 JP2021522240 A5 JP 2021522240A5
- Authority
- JP
- Japan
- Prior art keywords
- adhesive composition
- composition according
- approximately
- transdermal delivery
- delivery device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862662456P | 2018-04-25 | 2018-04-25 | |
| US62/662,456 | 2018-04-25 | ||
| PCT/US2019/028900 WO2019209940A1 (en) | 2018-04-25 | 2019-04-24 | Tetrabenazine transdermal delivery device |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021522240A JP2021522240A (ja) | 2021-08-30 |
| JP2021522240A5 true JP2021522240A5 (enExample) | 2022-04-20 |
| JP7386544B2 JP7386544B2 (ja) | 2023-11-27 |
Family
ID=68295781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020559388A Active JP7386544B2 (ja) | 2018-04-25 | 2019-04-24 | テトラベナジン経皮送達デバイス |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US12144899B2 (enExample) |
| EP (1) | EP3784237B1 (enExample) |
| JP (1) | JP7386544B2 (enExample) |
| KR (1) | KR102952482B1 (enExample) |
| CN (1) | CN112165942B (enExample) |
| AU (1) | AU2019261403B2 (enExample) |
| BR (1) | BR112020021700A2 (enExample) |
| CA (1) | CA3097189A1 (enExample) |
| DK (1) | DK3784237T3 (enExample) |
| ES (1) | ES2968827T3 (enExample) |
| IL (1) | IL278185B2 (enExample) |
| MX (1) | MX2020011269A (enExample) |
| TW (1) | TWI832854B (enExample) |
| WO (1) | WO2019209940A1 (enExample) |
| ZA (1) | ZA202006415B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3097189A1 (en) | 2018-04-25 | 2019-10-31 | Shinkei Therapeutics Llc | Tetrabenazine transdermal delivery device |
| US20220362165A1 (en) * | 2019-10-22 | 2022-11-17 | Shinkei Therapeutics Llc | Tetrabenazine transdermal delivery device |
| EP4125902A4 (en) * | 2020-03-30 | 2024-05-22 | Shinkei Therapeutics, Inc. | TRANSDERMAL ADMINISTRATION OF DEXTROMETHORPHAN |
| CN116036055A (zh) * | 2023-03-16 | 2023-05-02 | 上海世领制药有限公司 | 一种含甲磺酸雷沙吉兰的透皮贴剂及其制备方法 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63313723A (ja) * | 1987-06-16 | 1988-12-21 | Nitto Electric Ind Co Ltd | 外用貼付剤 |
| US5656286A (en) | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| JP4988080B2 (ja) * | 1997-09-05 | 2012-08-01 | 日東電工株式会社 | 経皮吸収型製剤 |
| EP1021204B1 (en) | 1997-09-26 | 2005-12-28 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
| US9056060B2 (en) * | 2000-09-19 | 2015-06-16 | Henkel Ag & Co. Kgaa | Non-reactive adhesive useful in transdermal drug delivery system |
| GB2410947B (en) | 2004-02-11 | 2008-09-17 | Cambridge Lab Ltd | Pharmaceutical compounds |
| EP1807033B1 (en) | 2004-10-08 | 2016-07-20 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device including an occlusive backing |
| WO2006053067A2 (en) | 2004-11-09 | 2006-05-18 | Prestwick Pharmaceuticals, Inc. | Combination of amantadine and a tetrabenazine compound for treating hyperkinetic disorders |
| GB0514501D0 (en) | 2005-07-14 | 2005-08-24 | Cambridge Lab Ireland Ltd | Pharmaceutical compounds |
| WO2011019956A2 (en) | 2009-08-12 | 2011-02-17 | Biovail Laboratories International (Barbados) S.R.L. | Pharmaceutical compositions |
| US20120208773A1 (en) * | 2008-08-12 | 2012-08-16 | Valeant International (Barbados) Srl | Pharmaceutical compositions with tetrabenazine |
| GB2462611A (en) | 2008-08-12 | 2010-02-17 | Cambridge Lab | Pharmaceutical composition comprising tetrabenazine |
| CA2972242A1 (en) | 2008-09-18 | 2010-04-22 | Auspex Pharmaceuticals, Inc. | Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| DE102010024105A1 (de) | 2010-06-17 | 2011-12-22 | Grünenthal GmbH | Transdermale Verabreichung von Memantin |
| AU2013243461A1 (en) * | 2012-04-04 | 2014-11-06 | Teva Pharmaceuticals International Gmbh | Pharmaceutical compositions for combination therapy |
| EP2872126B1 (en) * | 2012-07-16 | 2017-12-06 | Grünenthal GmbH | Pharmaceutical patch for transdermal administration of tapentadol |
| EP2999444A4 (en) * | 2013-05-20 | 2016-10-12 | Mylan Inc | ADVANCED TRANSDERMAL DOSAGE OF PRAMIPEXOL FOR THE TREATMENT OF NEUROLOGICAL DISEASES |
| AP2015008920A0 (en) * | 2013-06-04 | 2015-12-31 | Lohmann Therapie Syst Lts | Transdermal delivery system |
| EP3398602A1 (en) | 2014-01-27 | 2018-11-07 | Auspex Pharmaceuticals, Inc. | Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| CN106061506A (zh) | 2014-02-07 | 2016-10-26 | 纽罗克里生物科学有限公司 | 包含抗精神病药物和vmat2抑制剂的药物组合物及其用途 |
| NZ725826A (en) | 2014-05-06 | 2023-05-26 | Neurocrine Biosciences Inc | Vmat2 inhibitors for the treatment of hyperkinetic movement disorders |
| AR098771A1 (es) * | 2014-12-16 | 2016-06-15 | Amarin Tech S A | Un dispositivo para la administración transdérmica de rotigotina |
| AU2016229949B2 (en) | 2015-03-06 | 2021-04-08 | Auspex Pharmaceuticals Llc | Methods for the treatment of abnormal involuntary movement disorders |
| KR20240125709A (ko) | 2015-06-23 | 2024-08-19 | 뉴로크린 바이오사이언시즈 인코퍼레이티드 | 신경계 질환 또는 장애를 치료하기 위한 vmat2 억제제 |
| CN107847469A (zh) | 2015-06-27 | 2018-03-27 | 美国神农制药责任有限公司 | 氯胺酮透皮递送系统 |
| CN107028916B (zh) * | 2016-02-04 | 2020-05-12 | 北京泰德制药股份有限公司 | 含有布比卡因或其药用盐的皮肤外用制剂 |
| ITUB20161016A1 (it) * | 2016-02-24 | 2017-08-24 | Emenem Srl | Composizioni farmaceutiche o cosmetiche comprendenti un polimero e un promotore di assorbimento per il rilascio controllato di principi attivi |
| CN115813888A (zh) | 2016-12-20 | 2023-03-21 | 罗曼治疗系统股份公司 | 包含阿塞那平的透皮治疗系统 |
| CA3051830A1 (en) | 2017-01-27 | 2018-08-02 | Neurocrine Bioscienes, Inc. | Methods for the administration of certain vmat2 inhibitors |
| GB201705304D0 (en) | 2017-04-01 | 2017-05-17 | Adeptio Pharmaceuticals Ltd | Pharmaceutical compositions |
| US20190111035A1 (en) | 2017-04-01 | 2019-04-18 | Adeptio Pharmaceuticals Limited | Pharmaceutical compositions |
| CN110678181A (zh) | 2017-04-01 | 2020-01-10 | 阿德普蒂奥制药有限公司 | (+)-α-二氢丁苯那嗪在治疗运动障碍中的用途 |
| WO2018200605A1 (en) | 2017-04-26 | 2018-11-01 | Neurocrine Biosciences, Inc. | Use of valbenazine for treating levodopa-induced dyskinesia |
| EP3395336A1 (en) * | 2017-04-28 | 2018-10-31 | Nitto Denko Corporation | Transdermal absorption preparation |
| EP3664787B1 (en) | 2017-07-20 | 2022-07-20 | Neurolixis | Use of selective serotonin 5-ht1a receptor agonists for treating side-effects of vmat inhibitors |
| GB2565049B (en) | 2017-07-27 | 2020-06-10 | Reckitt Benckiser Health Ltd | A head assembly of a dermaplaning device |
| JP2021502959A (ja) | 2017-10-10 | 2021-02-04 | ニューロクライン バイオサイエンシーズ，インコーポレイテッド | 特定のｖｍａｔ２インヒビターを投与するための方法 |
| CA3097189A1 (en) | 2018-04-25 | 2019-10-31 | Shinkei Therapeutics Llc | Tetrabenazine transdermal delivery device |
| US20190374521A1 (en) | 2018-06-10 | 2019-12-12 | Axsome Therapeutics, Inc. | Methods of modulating tetrabenazine metabolites plasma levels using bupropion |
| AU2019287524A1 (en) | 2018-06-14 | 2020-12-24 | Neurocrine Biosciences, Inc. | VMAT2 inhibitor compounds, compositions, and methods relating thereto |
-
2019
- 2019-04-24 CA CA3097189A patent/CA3097189A1/en active Pending
- 2019-04-24 IL IL278185A patent/IL278185B2/en unknown
- 2019-04-24 TW TW108114349A patent/TWI832854B/zh active
- 2019-04-24 WO PCT/US2019/028900 patent/WO2019209940A1/en not_active Ceased
- 2019-04-24 DK DK19792500.1T patent/DK3784237T3/da active
- 2019-04-24 ES ES19792500T patent/ES2968827T3/es active Active
- 2019-04-24 AU AU2019261403A patent/AU2019261403B2/en active Active
- 2019-04-24 CN CN201980035258.6A patent/CN112165942B/zh active Active
- 2019-04-24 JP JP2020559388A patent/JP7386544B2/ja active Active
- 2019-04-24 BR BR112020021700-0A patent/BR112020021700A2/pt unknown
- 2019-04-24 KR KR1020207032380A patent/KR102952482B1/ko active Active
- 2019-04-24 MX MX2020011269A patent/MX2020011269A/es unknown
- 2019-04-24 US US17/050,230 patent/US12144899B2/en active Active
- 2019-04-24 EP EP19792500.1A patent/EP3784237B1/en active Active
-
2020
- 2020-10-15 ZA ZA2020/06415A patent/ZA202006415B/en unknown
-
2024
- 2024-10-10 US US18/911,581 patent/US20250144045A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7153010B2 (ja) | 塩薬物のｉｎ ｓｉｔｕでの塩から中性の薬物変換による、低溶解度または不安定非イオン化中性薬物の経皮配合物および送達方法 | |
| US20200277424A1 (en) | Silicone-containing acrylic polymers for transdermal drug delivery compositions | |
| US10987316B2 (en) | Compositions and methods for transdermal delivery of tertiary amine drugs | |
| JP4925823B2 (ja) | プラミペキソール活性剤を含む経皮治療システム | |
| JP2021522240A5 (enExample) | ||
| JP6359032B2 (ja) | 経皮薬物送達用のマルチポリマー組成物 | |
| CA2896336C (en) | Compositions and methods for transdermal delivery of non-steroidal anti-inflammatory agents | |
| US9717697B2 (en) | Compositions and methods for the transdermal delivery of methylphenidate | |
| US8852628B1 (en) | Transdermal drug delivery system for diclofenac | |
| US11376327B2 (en) | Stable transdermal amphetamine compositions and methods of manufacture | |
| CN103338771B (zh) | 贴剂 | |
| US20220023425A1 (en) | Stretchable backing layers for transdermal drug delivery systems | |
| US20170112781A1 (en) | Transdermal drug delivery systems with polyisobutylene face adhesive | |
| IL278185B1 (en) | Tetrabenazine transdermal delivery device | |
| US20130287823A1 (en) | Patch | |
| US20160128948A1 (en) | Patch | |
| RU2020138298A (ru) | Устройство для трансдермальной доставки тетрабеназина | |
| US20140370077A1 (en) | Transdermal drug delivery system containing fentanyl | |
| US20210251916A1 (en) | Transdermal therapeutic system containing rivastigmine | |
| WO2014159778A1 (en) | Transdermal drug delivery system containing fentanyl | |
| JP2018528176A5 (enExample) |